// App-Quantinova.ai

: A JAK2V617F Variant Allele Frequency Greater Than 50% Identifies Patients with Polycythemia Vera at High Risk for Venous Thrombosis

Researchers

Presenter

  • Giuseppe Gaetano Loscocco

Principal Investigators

  • Paola Guglielmelli

  • Carmela Mannarelli

  • Elena Rossi

  • Francesco Mannelli

  • Francesco Ramundo

  • Giacomo Coltro

  • Silvia Betti

  • Chiara Maccari

  • Sara Ceglie

  • Chiara Paoli

  • Tiziano Barbui

  • Ayalew Tefferi

  • Valerio De Stefano

  • Alessandro Vannucchi

Medical Centers

  • FROM Research Foundation Bergamo, Bergamo, Italy

  • University of Florence, AOU Careggi, CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Italy, Florence, Italy

  • Division of Hematology, Mayo Clinic, ROCHESTER, MN

  • Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A Gemelli, IRCCS, Rome, Italy

  • Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A Gemelli, IRCCS, Roma, Italy

Locations

  • Italy

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Central Nervous System (CNS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Angiology

Disease

  • Peripheral artery disease

  • Coronary Artery Disease

  • Deep vein thrombosis

  • Pulmonary embolism

  • Polycythemia vera

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A